Thrombocytopenia: all 703 studies
Page 7 of 8. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.
- Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell TransplantWithdrawnNCT01660347Not applicable
- Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult SubjectsCompletedNCT01657552Phase 1
- Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant RecipientsCompletedNCT01654848
- A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia PatientsCompletedNCT01621204Phase 3
- Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.CompletedNCT01618734
- Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)CompletedNCT01610180Phase 2
- Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced ThrombocytopeniaTerminatedNCT01598168Phase 3
- Human Placental-Derived Stem Cell TransplantationCompletedNCT01586455Phase 1
- A Multi-center Study of Low-dose Decitabine for the Treatment of Immune ThrombocytopeniaCompletedNCT01568333Phase 2
- Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune ThrombocytopeniaCompletedNCT01549184
- Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced ThrombocytopeniaCompletedNCT01516619Phase 2
- Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)CompletedNCT01506414Phase 3
- Eltrombopag for the Prevention of Chemotherapy Induced ThrombocytopeniaTerminatedNCT01491594Phase 1
- A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for ThrombocytopeniaCompletedNCT01488565Phase 2
- Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)CompletedNCT01481220Phase 1
- Honey in Chronic Immune ThrombocytopeniaTerminatedNCT01462916
- Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)WithdrawnNCT01443351
- A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.WithdrawnNCT01440361Phase 2
- Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)TerminatedNCT01397149Phase 1/2
- End of EXTEND: Discontinuation of Medication for Patients With Immune ThrombocytopeniaTerminatedNCT01386723
- Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and ThrombocytopeniaTerminatedNCT01362036Phase 1
- Effect of Hemodialysis Membranes on Platelet CountCompletedNCT01356576
- A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced ThrombocytopeniaTerminatedNCT01345214Phase 1
- Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor AntagonistsCompletedNCT01338363
- Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy SubjectsCompletedNCT01327872Phase 1
- Clinical Trial on the Prevention of Thrombocytopenia After First-line ChemotherapyTerminatedNCT01319669Phase 2/3
- Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune ThrombocytopeniaWithdrawnNCT01317966
- Vitamin B6 on Relieving Linezolid-associated CytopeniasStatus unknownNCT01295801
- A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy SubjectsCompletedNCT01289509Phase 1
- Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With ThrombocytopeniaTerminatedNCT01286038Phase 1
- Indirect Comparison Between Eltrombopag & RomiplostimCompletedNCT01236014
- Meta-analysis - EltrombopagCompletedNCT01235988
- The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP)TerminatedNCT01226524Phase 2/3
- Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological DisordersCompletedNCT01224496Phase 1/2
- Immune Thrombocytopenia (ITP) Immune-Genetic AssessmentStatus unknownNCT01196884
- Study of Eltrombopag in Platelet Refractory ThrombocytopeniaWithdrawnNCT01194167Phase 2
- Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During ChemotherapyCompletedNCT01163110Phase 1
- Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)Status unknownNCT01162941Phase 2
- Romiplostim in Treating Hepatitis C-Infected Patients With ThrombocytopeniaTerminatedNCT01153919Phase 2
- Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin ExposureStatus unknownNCT01102790
- The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.Status unknownNCT01101295
- Milk-only Lactation Study for Patients on EltrombopagWithdrawnNCT01055600Phase 4
- Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 AdultsCompletedNCT01013181
- Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeCompletedNCT00988715Phase 1
- Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)Status unknownNCT00946400
- Application of AS101 for the Treatment of Thrombocytopenia in Solid Tumor PatientsTerminatedNCT00926354Phase 2
- Phenotypic and Genotypic Identification and Characterization of MYH9-related Constitutional ThrombocytopeniaCompletedNCT00925236
- Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)CompletedNCT00903422Phase 1
- Argatroban Versus Lepirudin in Critically Ill PatientsTerminatedNCT00798525Phase 4
- Interleukin-2 Treatment for Wiskott-Aldrich SyndromeCompletedNCT00774358Phase 1
- Transfusing Neonates Based on Platelet MassCompletedNCT00759980
- Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) PatientsWithdrawnNCT00759083Phase 4
- Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation)CompletedNCT00748878
- Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive ClinicalCompletedNCT00748839
- Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00735930Phase 1
- Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood CellsCompletedNCT00730314Phase 1/2
- Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)CompletedNCT00682799
- Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer TreatmentCompletedNCT00608738Not applicable
- Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)WithdrawnNCT00603824Phase 4
- Registry for Vascular Anomalies Associated With CoagulopathyCompletedNCT00576888
- Thrombopoietin Levels and Platelet Transfusion in NeonatesCompletedNCT00549484
- Heparin-Induced Thrombocytopenia Score Card StudyCompletedNCT00489437Phase 1
- Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapyTerminatedNCT00471653
- Heparin-Induced Thrombocytopenia RegistryCompletedNCT00456326
- Heparin Induced Thrombocytopenia: PharmacoeconomicsCompletedNCT00456001
- Strategies for Transfusion of Platelets (SToP)TerminatedNCT00420914Phase 3
- Low Bacterial Diet in Patients With CytopeniaCompletedNCT00367588Not applicable
- Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And IfosfamideCompletedNCT00358540Phase 1
- Rituximab as Second Line Treatment for ITPCompletedNCT00344149Phase 3
- Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.CompletedNCT00336687
- Mechanism of Thrombocytopenia in InfantsCompletedNCT00333333
- Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First RemissionCompletedNCT00305708Phase 1/2
- Safety Study of AMG 531 in Japanese Subjects With ITPCompletedNCT00305435Phase 2
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficiency DiseaseCompletedNCT00295971Phase 1
- Heparin Antibodies in Intensive Care Unit Patients (HAICU)CompletedNCT00283322
- Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion ProductsCompletedNCT00263809Early Phase 1
- Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven DaysCompletedNCT00261924Phase 3
- A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or ThrombocytopeniaCompletedNCT00220311Phase 4
- A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular PatientsStatus unknownNCT00198575
- The HIT-TRAP TrialStatus unknownNCT00196417Phase 4
- Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus PlasmaCompletedNCT00151866Phase 3
- Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in ChildrenCompletedNCT00118664
- SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis CCompletedNCT00110799Phase 2
- SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving ChemotherapyCompletedNCT00102726Phase 2
- AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to SplenectomyCompletedNCT00102336Phase 3
- AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to SplenectomyCompletedNCT00102323Phase 3
- Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)CompletedNCT00073580Phase 3
- Daclizumab to Treat Chronic Immune ThrombocytopeniaCompletedNCT00049725Phase 2
- Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)CompletedNCT00043940Phase 3
- Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNCT00039910Phase 3
- Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to HeparinCompletedNCT00039858Phase 4
- Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of ThrombocytopeniaCompletedNCT00037791Phase 3
- Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic CancerCompletedNCT00031980Phase 2
- Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH CampusCompletedNCT00015639
- Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerCompletedNCT00012376Phase 1
- Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure SyndromesCompletedNCT00004787Phase 2
- Stem Cell Transplantation (SCT) for Genetic DiseasesCompletedNCT00004378Not applicable
- Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00004215Phase 2
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic LeukemiaCompletedNCT00003619Phase 1/2
- SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic LeukemiaCompletedNCT00002665Phase 2